Recall Enforment Report D-0060-2021

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by PD-Rx Pharmaceuticals, Inc., originally initiated on 10-06-2020 for the product metformin HCL ER 750 mg Rx only Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 tablets NDC: 43063-902-30; b) 60 tablets NDC: 43063-902-60 The product was recalled due to cgmp deviations: detection of n-nitrosodimethylamine (ndma) impurity above the acceptable intake level (per manufacturer). The product was distributed in Ak, Az, Ca, Co, Fl, Ga, Id, Il, In, Ky, Mn, Nc, Ny, Ok, Or, Wi and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0060-202110-06-202011-11-2020Class II125 bottlesmetformin HCL ER 750 mg Rx only Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 tablets NDC: 43063-902-30; b) 60 tablets NDC: 43063-902-60CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)Terminated
D-0059-202110-06-202011-11-2020Class II1683 bottlesmetformin HCL ER 500 mg, a) 30 tablets NDC: 72789-009-30; b) 60 tablets NDC: 72789-009-60; c) 90 tablets NDC: 72789-009-90; d) 180 tablets NDC: 72789-009-93 bottles, Rx only, Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)Terminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
43063-902Metformin Hydrochloride Extended Release Metformin HydrochlorideTablet, Extended ReleaseOralPd-rx Pharmaceuticals, Inc.Human Prescription Drug
72789-009Metformin Hydrochloride Extended Release Metformin HydrochlorideTablet, Extended ReleaseOralPd-rx Pharmaceuticals, Inc.Human Prescription Drug